Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership

About this update from Kaneka Corporation

[{"type":"image","alt":"Toro Neurovascular","displaySize":"","headline":null,"caption":"Toro Neurovascular","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":103,"url":"https://media.zenfs.com/en/globenewswire.com/e40497cebe77a6717e10819f9f8f5afe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/n7SU5TvjC4NqGVq7uTeCig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e40497cebe77a6717e10819f9f8f5afe","width":300,"height":103}},"lazy":false},{"type":"text","content":"Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval","length":110,"tagName":"p"},{"type":"text","content":"Toro Hero","length":9,"tagName":"p"},{"type":"image","alt":"Toro Neurovascular’s catheter technology, developed for the treatment of neurovascular disease.","displaySize":"","headline":null,"caption":"Toro Neurovascular’s catheter technology, developed for the treatment of neurovascular disease.","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1920,"height":1080,"url":"https://media.zenfs.com/en/globenewswire.com/0e6723adaea674889d0403adccde200e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pTnGvYd4K2F01DBzxHdHsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0e6723adaea674889d0403adccde200e","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sV8u.zrAGrLNJIg5Y9uiUA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/0e6723adaea674889d0403adccde200e","width":1200,"height":675}}},{"type":"text","content":"IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Toro Neurovascular, a company pioneering advanced catheter technologies for neurovascular intervention, today announced an exclusive distribution partnership with Kaneka Medical America for Toro’s novel neurovascular catheter portfolio in the U.S. market, pending regulatory clearance.“Partnering with Kaneka accelerates our mission to equip physicians with tools that make the most challenging neurovascular procedures more predictable and controlled,” said Hyung Posalit, CEO of Toro Neurovascular. “Kaneka’s strong commercial infrastructure and shared commitment to clinical excellence make them an ideal partner ...

More updates from Kaneka Corporation